Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment

NCT00296153 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Immunodeficiency Virus
Ischemic Heart Disease

Interventions

DRUG: Omega-3-acid ethyl esters 90

Sponsor

Pronova BioPharma

Collaborators

[object Object]